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We used the dataset from one medical center in Taiwan to explore the prevalence of dyslipidemia, which included 2695 subjects
receiving private health checkups in 2003-2004. The overall prevalence of hypercholesterolemia was 53.3% in men and 48.2% in
women (P = 0.008). The overall prevalence of hypertriglyceridemia was 29.3% in men and 13.7% in women (P<0.001). The
overall prevalence of elevated LDL level was 50.7% in men and 37.9% in women (P<0.001). The overall prevalence of low HDL
level was 47.4% in men and 53% in women (P = 0.004).
We analyzed 2695 subjects who received private health
checkups at their own expense at one medical center located
at the Taichung city in mid-Taiwan from 2003 to 2004. There
were 1526 men (56.6%) and 1169 women (43.4%). The
mean age was 49.2 years old (standard deviation 12.2, range
from 20 to 84). Hypercholesterolemia was deﬁned as total
cholesterol level ≥200mg/dL [1]. Hypertriglyceridemia was
deﬁned as triglyceride level ≥150mg/dL [2]. Elevated low-
density lipoprotein cholesterol (LDL) level was deﬁned as
LDLlevel≥130mg/dL[2].Lowlevelofhigh-densitylipopro-
tein cholesterol (HDL) was deﬁned as HDL <40mg/dL in
men and <50mg/dL in women [2].
In Figure 1, the overall prevalence of hypercholes-
terolemia was 53.3% in men and 48.2% in women (P =
0.008). In the group aged 20 to 39, men had higher preva-
lenceofhypercholesterolemiathanwomendid(48.2%versus
22.6%, P < 0.001). In the group aged 65 and over, women
had higher prevalence than men did (63.5% versus 47.2%,
P = 0.003). There was no signiﬁcant diﬀerence between men
and women in the group aged 40 to 64 (55.9% versus 53.8%,
P =0.368).Theprevalenceofhypercholesterolemiaincreased
with age in women (P < 0.001).
In Figure 2, the overall prevalence of hypertriglycer-
idemia was 29.3% in men and 13.7% in women (P < 0.001).
Men had higher prevalence of hypertriglyceridemia than
women did in the group aged 20 to 39 and in the group
aged 40 to 64 (P < 0.001 and P < 0.001, resp.). There was
no signiﬁcant diﬀerence between men and women in the
group aged 65 and over (18.2% versus 26.4%, P = 0.077).
The prevalence of hypertriglyceridemia increased with age in
women (P < 0.001).
In Figure 3, the overall prevalence of elevated LDL level
was 50.7% in men and 37.9% in women (P < 0.001). Men
had higher prevalence of elevated LDL level than women
did in the group aged 20 to 39 and in the group aged
40 to 64 (P < 0.001 and P < 0.001, resp.). There was no
signiﬁcant diﬀerence between men and women in the group
aged 65 and over (46.0% versus 48.6%, P = 0.637). The
prevalenceofelevatedLDLlevelincreasedwithageinwomen
(P < 0.001).
In Figure 4, the overall prevalence of low HDL level was
47.4% in men and 53% in women (P = 0.004). Women had
higher prevalence of low HDL level than men did in the
g r o u pa g e d4 0t o6 4a n di nt h eg r o u pa g e d6 5a n do v e r
(P = 0.047 and P = 0.001, resp.). There was no signiﬁcant
diﬀerence between men and women in the group aged 20 to
39 (46.3% versus 47.1%, P = 0.857). The prevalence of low
HDL level increased with age in women (P = 0.014).2 Cholesterol
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Figure 1: Prevalence of hypercholesterolemia in gender and three
age groups.
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Figure 2: Prevalence of hypertriglyceridemia in gender and three
age groups.
In 2010, cardiovascular disease and cerebrovascular
disease are the second and the third leading causes of
death in Taiwan [3] .P r e v i o u sr e p o r t sh a v es u g g e s t e d
dyslipidemia, including hypercholesterolemia (elevated total
cholesterol level), hypertriglyceridemia, elevated LDL level,
and low HDL level, is a major risk factor for cardiovascular
disease and ischemic stroke [4–6]. In this present study,
the overall prevalence of dyslipidemia is relatively high,
including hypercholesterolemia 51.1%, hypertriglyceridemia
22.5%, elevated LDL level 45.1%, and low HDL level 49.8%.
In addition, the prevalence rates of hypercholesterolemia,
hypertriglyceridemia, elevated LDL level, and low HDL
level signiﬁcantly increase with age in women. That is, the
prevalence of dyslipidemia in women is lower in the group
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Figure 3: Prevalence of elevated LDL level in gender and three age
groups.
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Figure 4: Prevalence of low HDL level in gender and three age
groups.
aged20–39thaninthegroupaged40andover,butnosimilar
trend is found in men. This result further reveals that the
statusofallserumlipidsinwomenaged20–39issigniﬁcantly
better than the other age groups. However, in this dataset,
therewasonlyblooddata,nomentionwhetherthesepatients
were using lipid-lowering drugs. Thus, the prevalence of
dyslipidemia might be underestimated. Meanwhile, we hope
these ﬁndings are to guide public health interventions to
manage dyslipidemia issue in Taiwan.
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